| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.09 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.09 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.1 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.1 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.1 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.1 |